Skip to content
NEW: CREATE AN AI-ASSISTED TENDER IN 2 MINUTES — TRY IT FREE
Back to search

Development of genetically modified microorganisms and bioprocesses for the biosynthetic production of fine chemicals

SY

Synbionik GmbH

Frankfurt am Main (Weismüllerstr. 50)New on Amplifa

2018Founded
51–100Employees (according to Crunchbase)
Commercial register

About Synbionik

Synbionik is a European biotechnology company based in Frankfurt am Main, specializing in Synthetic Biology. The company designs and constructs genetically modified microorganisms capable of producing target compounds from simple, low-cost substrates such as glucose. The service spans the entire process: from evaluation and concept development through AI-assisted selection of genetic building blocks and metabolic engineering to optimization of the production organisms. Subsequently, cultivation and process conditions are developed, quantitative analysis and product isolation are established, and the bioprocesses are scaled up in bioreactors and commercialized. In addition, Synbionik designs and constructs bioreactor prototypes. Target industries are the fine chemicals and pharmaceutical industries as well as industrial applications. The management consists of Christoph Oldenburg (CEO) and Linus Willems (CCO); according to Crunchbase, the company employs 51–100 staff.

Site
Frankfurt am Main
Processes
Synthetic Biology / Biosynthesis of genetically modified microorganisms (metabolic engineering), Microorganism design and construction (genetic engineering), Upscaling & bioprocess commercialization in bioreactors (fermentation), Design and construction of tailored microorganisms, Optimization of production organisms, Optimization of bioprocesses / upscaling in bioreactors, AI-assisted analysis and selection of genetic building blocks, Cultivation and quantitative analysis
Founded
2018-05-28
Industries
Biotechnology, Synthetic Biology, Fine Chemicals, Pharmaceutical Industry
  1. 01

    Evaluation & legal review

  2. 02

    Concept development & selection

  3. 03

    Construction & optimization of the microorganisms

  4. 04

    Cultivation & analysis

  5. 05

    Upscaling & commercialization in bioreactors

Location

Frankfurt am Main

DE

Headquarters, development and cultivation

  • Bioreactors (fermenters)
  • Cultivation systems of various scales

Industries

BiotechnologySynthetic BiologyFine ChemicalsPharmaceutical Industry

Processes & technical limits

ProcessesToleranceMax. partWeightLot sizeMaterials
Synthetic Biology / Biosynthesis of genetically modified microorganisms (metabolic engineering)Engineering––––Glucose (substrate)
Microorganism design and construction (genetic engineering)Engineering–––––
Testing–––––
Upscaling & bioprocess commercialization in bioreactors (fermentation)Engineering–––––

2 Anlagen & Maschinen

MachineManufacturer / modelQuantityWorking areaYear builtSite
Bioreactor (fermenter)––––Frankfurt am Main
Cultivation systems of various scales–––––

Additional services

Design and construction of tailored microorganismsOptimization of production organismsOptimization of bioprocesses / upscaling in bioreactorsAI-assisted analysis and selection of genetic building blocksCultivation and quantitative analysisProduct isolationCommercialization of genetically modified microorganismsConception and construction of bioreactor prototypes

History

  1. 2018

    Founding of Synbionik GmbH on 28.05.2018, originally based in Berlin (Rosa-Luxemburg-Str. 2)

  2. 2020

    Linus Willems becomes managing director on 12.10.2020 (previously authorized officer), Christoph Oldenburg on 09.11.2020; relocation of the company seat to Frankfurt am Main

  3. 2020

    Exhibitor at SynBioBeta 2020, the global conference for Synthetic Biology

Personalised demo

Ready to see Amplifa Marketplace in action?

From a structured request to the right manufacturing partner: AI-assisted matching, verified suppliers and transparent metrics — in one place for industrial companies across the DACH region.

Request a demo